Lord, Abbett & Co’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
Other funds holding GWPH
BG
Lord, Abbett & Co's GWPH Position: Q3 2020 in Review
Lord, Abbett & Co sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2020, closing a stake of 116,845 shares — an estimated $14.3M sold.
Lord, Abbett & Co first reported a position in GWPH in Q1 2014 and held it in 12 quarters. The position peaked at $109M in Q3 2018. 279 funds tracked by Wall St. Rank hold GWPH as of Q3 2020.
- Lord, Abbett & Co reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2020 after selling out during the quarter.
- Lord, Abbett & Co sold 116,845 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2020, an estimated $14.3M.
- Lord, Abbett & Co first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2014 and held it in 12 quarters.
- Lord, Abbett & Co's GW Pharmaceuticals Plc American Depositary Shares position peaked at $109M in Q3 2018.
- 279 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2020.
Based on Lord, Abbett & Co's 13F filing for Q3 2020, filed 12 Nov 2020.